X4 Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule i…

Biotechnology
US, Boston [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

X4 Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

X4 Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of X4 Pharmaceuticals, Inc..

End of XFOR's Analysis
CIK: 1501697 CUSIP: 98420X103 ISIN: US98420X1037 LEI: - UEI: -
Secondary Listings
XFOR has no secondary listings inside our databases.